A drug called Aviptadil shows promise in defeating the syndrome that accounts for around half of all corona-related deaths.

An Israeli company called Neurorx‏ is currently testing a drug called Aviptadil, which could treat acute respiratory distress syndrome (ARDS), the condition responsible for around 50% of all coronavirus fatalities.

On Sunday, the U.S. Food and Drug Administration gave approval to NeuroRx for phase two trials of Aviptadil.

While this is not a complete drug approval for Covid-19-related use of the drug, it does mean the treatment is one step closer to getting the greenlight for patient use.

HELP ISRAELIS BATTLE CORONA!

Donate to the Corona Emergency Relief Fund. Coronavirus has taken a huge toll on the people of Israel. The poor, elderly and ill are most vulnerable.

Israeli soldiers, security officers and medical care providers operate under great danger and risk to life.

Over 1 million Israelis are out of work. Many cannot make ends meet. We provide financial aid, food, medical supplies and more. Funds are distributed where needed most. The time to act is now!

United with Israel extends a special note of appreciation to the Genesis Prize for their generous support.

CLICK HERE TO HELP THE PEOPLE OF ISRAEL TODAY!